Dose Matters: The Importance of Appropriate Dosing: A Case Report on Sunitinib Treatment in a Patient With Metastatic Renal Cell Carcinoma

被引：1
|
作者：
Bojic, Marija [1 ]
Schmidinger, Manuela [1 ]
机构：
[1] Med Univ Vienna, A-1090 Vienna, AT, Austria
来源：
CLINICAL GENITOURINARY CANCER | 2012年 / 10卷 / 04期
关键词：
Dosing; Metastatic renal cell carcinoma; Tyrosine kinase inhibitor; INTERFERON-ALPHA; PHASE-3; TRIAL;
D O I：
10.1016/j.clgc.2012.04.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 279
页数：3
相关论文
共 50 条
  • [31] Case Report of Akathisia in a Patient With Metastatic Renal Cell Carcinoma on Nivolumab
    Ho, Sarah X.
    Gass, Elizabeth
    Ruark, Julia M.
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2021, 62 (01): : 119 - 122
  • [32] Case report of a patient being treated for metastatic renal cell carcinoma
    Langiewicz, Przemyslaw
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : A25 - A26
  • [33] PRELIMINARY REPORT OF SUNITINIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (CHINA)
    Hu, X.
    Guo, J.
    Lin, Z.
    Sun, L.
    Xu, Z.
    Cang, C.
    Wang, G.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : I6 - I7
  • [34] Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the point
    Ferrer, Florent
    Chauvin, Jonathan
    Deville, Jean-Laurent
    Ciccolini, Joseph
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (04) : 565 - 569
  • [35] Tislelizumab combined with sunitinib in the treatment of metastatic clear cell renal cell carcinoma with renal venous tumor thrombus: A case report and literature review
    Gao, Zhixiang
    Jin, Lu
    Lv, Haijun
    Duan, Nengliang
    Zhang, Guoneng
    Ran, Yuanshuai
    Xue, Boxin
    Liu, Xiaolong
    UROLOGY CASE REPORTS, 2024, 54
  • [36] Complete Response After Sequential Sunitinib-Sorafenib Treatment in a Patient With Renal Cell Carcinoma: A Case Report
    Verzoni, Elena
    Lanocita, Rodolfo
    Procopio, Giuseppe
    CLINICAL GENITOURINARY CANCER, 2012, 10 (02) : 130 - 133
  • [37] Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the point
    Florent Ferrer
    Jonathan Chauvin
    Jean-Laurent Deville
    Joseph Ciccolini
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 565 - 569
  • [38] UNCOMMON SIDE EFFECTS OF SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CANCER: CASE REPORT
    Separovic, Robert
    Pavlovic, Mirjana
    Silovski, Tajana
    Silovski, Hrvoje
    Vuger, Ana Tecic
    ACTA CLINICA CROATICA, 2018, 57 (03) : 577 - 580
  • [39] Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report
    Masaki Murata
    Yohei Ikeda
    Go Hasegawa
    Yuki Nakagawa
    Tsutomu Nishiyama
    Journal of Medical Case Reports, 13
  • [40] Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report
    Murata, Masaki
    Ikeda, Yohei
    Hasegawa, Go
    Nakagawa, Yuki
    Nishiyama, Tsutomu
    JOURNAL OF MEDICAL CASE REPORTS, 2019, 13 (01)
12345